Misplaced Pages

Prelude Fertility

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
American fertility clinics
This article may have been created or edited in return for undisclosed payments, a violation of Misplaced Pages's terms of use. It may require cleanup to comply with Misplaced Pages's content policies, particularly neutral point of view. (December 2020)
Prelude Fertility
Company typePrivate
Industry
FounderMartin Varsavsky
Key peopleTJ Farnsworth (CEO)
Services
  • Fertility Services
  • In Vitro Fertilization
  • Egg Freezing
  • Egg Donation
Websitehttps://www.preludefertility.com/

Prelude Fertility is a network of fertility clinics in the United States that offer fertility services including in vitro fertilization (IVF), egg donation, genetic testing, and egg freezing. As of 2019, the Prelude Fertility Network of clinics included 23 fertility practices and 36 locations in the U.S. and more than 60 affiliated reproductive endocrinologists.

History

Prelude Fertility was founded by Martin Varsavsky following his and his wife’s experience with fertility treatment and IVF.

The company launched in October 2016 when Varsavsky secured funding from Lee Equity Partners to purchase a majority stake in Reproductive Biology Associates, an IVF clinic in Atlanta, and My Egg Bank, the largest frozen donor egg bank in the U.S.

In September 2017, Prelude acquired a majority stake in Pacific Fertility Center in San Francisco. The following month, Prelude acquired Vivere Health. In March 2018, Prelude acquired the Advanced Fertility Center of Chicago. In October 2018, Prelude announced a partnership with NYU Langone. In March 2019, Prelude announced a partnership with Inception Fertility and also announced TJ Farnsworth as the company’s new CEO. The partnership made Prelude the largest fertility services provider in the U.S and added Aspire Fertility clinics to the Prelude Network.

References

  1. ^ Helft, Miguel. "Meet Prelude Fertility, The $200 Million Startup That Wants To Stop The Biological Clock". Forbes. Archived from the original on October 19, 2016. Retrieved 2019-05-31.
  2. ^ "Investors see big money in infertility. And they're transforming the industry". STAT. 2017-12-04. Retrieved 2019-05-31.
  3. "Prelude Fertility, Inception to combine operations". Verdict Hospital. 2019-03-29. Retrieved 2019-05-31.
  4. "Prelude Fertility aims to give women and couples a choice on the timing of a family". TechCrunch. 20 October 2016. Retrieved 2019-05-31.
  5. Ramsey, Lydia. "A startup that raised $200 million wants you to think about fertility long before you want to start a family". Business Insider. Retrieved 2019-05-31.
  6. Ho, Catherine (2017-09-27). "Private equity-backed firm acquires majority of San Francisco's Pacific Fertility Center". SFGate. Retrieved 2019-05-31.
  7. Snyder, Eric (31 October 2017). "Franklin health care company selling to NY firm". www.bizjournals.com. Retrieved 2019-05-31.
  8. GmbH, finanzen net. "Prelude Fertility Partners with Advanced Fertility Center of Chicago, Expanding the Prelude Network to 4th Largest IVF Market in the U.S. | Markets Insider". markets.businessinsider.com. Retrieved 2019-05-31.
  9. "MarketWatch: NYU Langone's Innovative Partnership with Prelude Fertility to Expand Scope of Services". NYU Langone News. Retrieved 2019-05-31.
  10. ^ Taylor, Seema Mody, Harriet (2019-05-09). "Egg freezing has become the go-to for delayed parenthood – and companies are popping up to provide more cost-effective solutions". CNBC. Retrieved 2019-05-31.{{cite web}}: CS1 maint: multiple names: authors list (link)
  11. "Demand for fertility services continues to increase - ExpressNews.com". www.expressnews.com. 2019-04-11. Retrieved 2019-05-31.
Categories: